Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
The vector of anti-CLDN18A2 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target Human CLDN18A2. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-CLDN18A2 antibody linked to CD28 and CD3_ signaling domains.
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.